✦ LIBER ✦

Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation

✍ Scribed by Judy C. Boughey; Jamie Wagner; Betsy J. Garrett; Lori Harker; Lavinia P. Middleton; Gildy V. Babiera; Funda Meric-Bernstam; Anthony Lucci; Kelly K. Hunt; Isabelle Bedrosian

Book ID: 111772961
Publisher: Springer
Year: 2009
Tongue: English
Weight: 176 KB
Volume: 16
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-009-0402-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant Chemotherapy Increases the R

Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients

✍ Florian Fitzal; Martina Mittlboeck; Guenther Steger; Rupert Bartsch; Margaretha 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 365 KB

Surgical Margins in Breast-Conservation

Surgical Margins in Breast-Conservation Operations for Invasive Carcinoma: Does Neoadjuvant Chemotherapy Have an Impact?

✍ Geneviève Soucy; Julie Bélanger; Guy Leblanc; Lucas Sideris; Pierre Drolet; Andr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Adjuvant extension of chemotherapy after

Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer

✍ M. Knauer; A. Haid; Y. Schneider; R. Köberle-Wührer; A. Lang; T. Winder; R. Alto 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 254 KB

High rates of breast conservation for la

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

✍ Bollet, M A; Savignoni, A; Pierga, J-Y; Lae, M; Fourchotte, V; Kirova, Y M; Dend 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Invasive ductal carcinoma and invasive l

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel

✍ Catharina Wenzel; Rupert Bartsch; Dagmar Hussian; Ursula Pluschnig; Gabriela Alt 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 142 KB

Despite limited data, coexistent lobular

Despite limited data, coexistent lobular carcinoma in situ should not be a contraindication to breast conservation for women with invasive breast carcinoma

✍ Harry D. Bear; W. Hans Carter Jr.; Margaret M. Grimes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

L ong after prospective randomized trials demonstrated equivalent survival with breast-conserving treatment (BCT) and mastectomy for breast carcinoma patients, BCT is used less than would be expected, particularly in certain regions of the United States. 1,2 Many different reasons have been given fo